Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022011338 - KINASE MODULATORS AND METHODS OF USE THEREOF

Publication Number WO/2022/011338
Publication Date 13.01.2022
International Application No. PCT/US2021/041271
International Filing Date 12.07.2021
IPC
C07D 249/04 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
249Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
02not condensed with other rings
041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
CPC
C07D 249/06
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
249Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
02not condensed with other rings
041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
06with aryl radicals directly attached to ring atoms
C07D 249/08
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
249Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
02not condensed with other rings
081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
C07D 401/12
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
401Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
02containing two hetero rings
12linked by a chain containing hetero atoms as chain links
C07D 401/14
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
401Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
14containing three or more hetero rings
C07D 403/12
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
403Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
02containing two hetero rings
12linked by a chain containing hetero atoms as chain links
C07D 403/14
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
403Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
14containing three or more hetero rings
Applicants
  • ORIGENIS GMBH [DE]/[DE]
  • NEURON23, INC. [US]/[US]
Inventors
  • KOESTLER, Roland
  • YEHIA, Nasser
  • TASSEL, Jean
  • WEGMANN, Marcus
  • MEDDA, Federico
  • PEREZ-GALAN, Patricia
  • GILCH, Christiane
  • THORMANN, Michael
  • TREML, Andreas
  • ALMSTETTER, Michael
  • PEI, Zhonghua
  • SAVAGE, Scott
Agents
  • SCHOEN, Adam M.
  • HYDE, Zachary, D.
  • DIBERNARDO, Ian, G.
  • MEYERS, Thomas, C.
  • NICKAS, Mark
Priority Data
63/050,38510.07.2020US
63/137,81615.01.2021US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) KINASE MODULATORS AND METHODS OF USE THEREOF
(FR) MODULATEURS DE KINASE ET LEURS PROCÉDÉS D'UTILISATION
Abstract
(EN) The present invention relates to novel compounds that modulate the activity of one or more kinases, such as TYK2 or mutants thereof. The compounds, which may be kinase inhibitors or activators, are useful for treating autoimmune diseases, such as, such as psoriasis, lupus, multiple sclerosis, and inflammatory bowel disease.
(FR) La présente invention concerne de nouveaux composés qui modulent l'activité d'une ou de plusieurs kinases, par exemple TYK2 ou des mutants associés. Les composés, qui peuvent être des inhibiteurs ou des activateurs de kinase, sont utiles pour le traitement de maladies auto-immunes, telles que le psoriasis, le lupus, la sclérose en plaques et la maladie intestinale inflammatoire.
Latest bibliographic data on file with the International Bureau